Proteostasis as a fundamental principle of Tau immunotherapy.

tilavonemab (ABBV-8E12) - AbbVie

http://www.ncbi.nlm.nih.gov/pubmed/39074206

Ashley J van Waardenberg; Bradley J Connor; Esteban Cruz; Godfrey Nkajja; Jürgen Götz; Mark E Graham; Phil Robinson; Pranesh Padmanabhan; Rebecca M Nisbet; Swara Tapaswi

Jul 29, 2024